This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kakizoe, S. Articles by Pugh, T. D. Search for Related Content PubMed PubMed Citation Articles by Kakizoe, S. Articles by Pugh, T. D.

Focal Impairment of Growth in Hepatocellular Neoplasms of C57BL/6 Mice: A Possible Explanation for the Strain's Resistance to Hepatocarcinogenesis¹

Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine, Madison, Wisconsin 53706

C57BL/6 mice are relatively more resistant to hepatocarcinogens than C3H and C57BL/6 x C3H F₁ (hereafter called B6C3F₁) mice; however, the basis for this strain-dependent difference is not clear. In order to address this issue, male C57BL/6 mice were treated i.p. with 5 mg/kg diethylnitrosamine when 15 days old and the histological features of induced hepatocellular neoplasms were assessed at intervals over the ensuing 80 weeks. In many respects the natural history of the tumors was similar to that previously reported for hepatic neoplasms in B6C3F₁ mice; they invaded hepatic vein branches while still microscopic (18 weeks after diethylnitrosamine) and developed into metastasizing trabecular carcinomas by 80 weeks. However, the tumors in the C57BL/6 mice were unique in their early focal development of cells containing inclusions of secretory protein within the endoplasmic reticulum. At 12 weeks after diethylnitrosamine, more than 90% of the neoplasms contained inclusions. Over the ensuing months, the inclusions increased in size and number and the regions containing them became more sharply defined. In mice killed 48 weeks after carcinogen, the extent of inclusion formation was correlated with [³H]thymidine labeling indices. Mean labeling indices were higher in the inclusion-poor than in the inclusion-rich areas: 5.4% versus 1.5% for the 36 neoplasms smaller than 1 mm in diameter and 14% versus 6% for the 18 neoplasms larger than 1 mm. Thus, we suggest that the focal slowing of hepatocellular tumor growth in C57BL/6 mice contributes to the strain's apparent resistance to hepatocarcinogenicity. However, the impairment does not appear to block tumor progression and the ultimate development of trabecular carcinomas. In addition, the data indicate that, independent of the presence or absence of inclusions, larger tumors have higher labeling indices, and presumably higher growth rates, than smaller ones. While the reason for the association between cytoplasmic inclusions and the low labeling indices is not known at present, at the very least the inclusions serve as unique markers for the growth retardation.

¹ Supported by NIH Grant ES03616. Presented in part at the 1988 meeting of the American Association for Cancer Research, New Orleans, LA.

² Present address: Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA.

³ To whom requests for reprints should be sent.

Received 5/12/88. Revised 3/ 3/89. Accepted 4/18/89.

This article has been cited by other articles:

				A. Bilger, L. M. Bennett, R. A. Carabeo, T. A. Chiaverotti, C. Dvorak, K. M. Liss, S. A. Schadewald, H. C. Pitot, and N. R. Drinkwater A Potent Modifier of Liver Cancer Risk on Distal Mouse Chromosome 1: Linkage Analysis and Characterization of Congenic Lines Genetics, June 1, 2004; 167(2): 859 - 866. [Abstract] [Full Text] [PDF]

				K. Takahashi, G. E. Dinse, J. F. Foley, J. F. Hardisty, and R. R. Maronpot Comparative Prevalence, Multiplicity, and Progression of Spontaneous and Vinyl Carbamate-Induced Liver Lesions in Five Strains of Male Mice Toxicol Pathol, August 1, 2002; 30(5): 599 - 605. [Abstract] [PDF]

				Z.-Q. Zhou, D. Manguino, K. Kewitt, G. W. Intano, C. A. McMahan, D. C. Herbert, M. Hanes, R. Reddick, Y. Ikeno, and C. A. Walter Spontaneous hepatocellular carcinoma is reduced in transgenic mice overexpressing human O6- methylguanine-DNA methyltransferase PNAS, October 12, 2001; (2001) 221232998. [Abstract] [Full Text] [PDF]

				J. G. Evans, M. A. Collins, B. G. Lake, and W. H. Butler The Histology and Development of Hepatic Nodules and Carcinoma in C3H/He and C57BL/6 Mice Following Chronic Phenobarbitone Administration Toxicol Pathol, January 1, 1992; 20(4): 585 - 594. [Abstract] [PDF]

				Z.-Q. Zhou, D. Manguino, K. Kewitt, G. W. Intano, C. A. McMahan, D. C. Herbert, M. Hanes, R. Reddick, Y. Ikeno, and C. A. Walter Spontaneous hepatocellular carcinoma is reduced in transgenic mice overexpressing human O6- methylguanine-DNA methyltransferase PNAS, October 23, 2001; 98(22): 12566 - 12571. [Abstract] [Full Text] [PDF]